ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Sudish Murthy
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murthy, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murthy, S.

Ann Thorac Surg 2005;80:1239-1240
© 2005 The Society of Thoracic Surgeons

Original article: General thoracic

Invited commentary

Sudish Murthy, MD, PhD

Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, 9500 Euclid Ave, Desk F-24, Cleveland, OH44195

(Email: murthys1@ccf.org).

The first 20% of the full text of this article appears below.

Accurate mediastinal lymph node staging is critical for proper management of non-small cell lung cancer, as only those patients without evidence of mediastinal (N2) involvement can be clearly shown to benefit from up-front resection. Several techniques are available for evaluating the mediastinum, each with its own inherent liabilities. It will likely take a synergistic blending of these existing techniques to arrive at the most complete assessment of the mediastinum.

To this end, the authors [. . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The Society of Thoracic Surgeons.